Objective:

To review all published clinical data regarding the prophylactic application of resorbable gentamicin collagen implants (GCI) specifically following gastrointestinal surgery.

Key Findings:

• GCI significantly reduced wound infection rates compared to control groups (13% vs 40%), indicating a substantial benefit in SSI prevention.
• GCI application led to faster wound healing and shorter hospital stays, suggesting improved recovery outcomes.
• Seven out of nine studies were graded as level 1 evidence, reinforcing the reliability of the findings.

Interpretation:

The use of GCI in high-risk gastrointestinal surgeries appears to effectively reduce the incidence of surgical site infections and improve recovery outcomes, potentially influencing clinical guidelines.

Limitations:

• Limited number of studies specifically focused on gastrointestinal surgery, which may affect the generalizability of the findings.
• Variability in study designs and patient populations could introduce bias and limit the strength of the conclusions drawn.

Conclusion:

The growing body of evidence supports the efficacy of GCI in reducing surgical site infections and improving recovery metrics in high-risk gastrointestinal surgical procedures, particularly in light of rising antibiotic resistance.